hims hers semaglutide Despite the Stigma, & Isn't Backing Away From Weight-Loss Drugs Hims & Hers announces access

As a next-generation triple agonist targeting GLP-1, GIP, and glucagon receptors, Phase 2 data demonstrated substantial effects on weight reduction and metabolic parameters, placing the molecule at the center of scientific and industry discussions

10.1038/nm.3009 42 FlorianH.WangD.ArnoldS

Beyond Cortisol Retatrutide does more than alter cortisol

Protocol: Started at 0.5mg weekly (weeks 1-2), increased to 1mg weekly (weeks 3+)

248 Interestingly, in 2008 a study found that the GLP-1 metabolite GLP-1 (936) afforded significant protection against ischemia-reperfusion injury in mice and induced vasodilation in a GLP-1R independent manner